InsiderTrades

Form 4 for LIF Life360, Inc.

Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-07 · accession 0001415889-24-016456 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2024-06-11 2024-06-07 LIF Hulls Chris CEO, Dir S - Sale $27.00 -269.3K 1.94M -12% -$7.27M
I 2024-06-11 2024-06-07 LIF Hulls Chris CEO, Dir S - Sale $27.00 -19.8K 10.2K -66% -$533.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common stock 2024-06-07 S D 269,335 $27.00 1,939,542 D — — (F1) Includes 86,554 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
2 Common Common stock 2024-06-07 S D 19,759 $27.00 10,201 I Held by ICCA Labs, LLC — — (F2) Represents shares of the Issuer's common stock underlying 30,603 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. (F3) The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 45,425 shares of the Issuer's common stock underlying 136,275 CDIs. The number of shares sold and held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.